Some studies, such as the ARIC cohort in the United States [7], have shown that elevated levels of Lp(a) in Caucasians with diabetes or prediabetes were associated with an increased risk of atheromatous cardiovascular disease and that the addition of Lp(a) to traditional risk factors improved the prediction of cardiovascular risk. This evidence concerns the gene LPA and cardiovascular disorder.